“Don't work for this company as long as Martin McGlynn is in charge - Extremely poor management at the helm. ”
- Work/Life Balance
- Career Opportunities
- Comp & Benefits
- Senior Management
I worked at StemCellsDoesn't RecommendDisapproves of CEODoesn't RecommendDisapproves of CEO
The scientific endeavors are tremendous and quality people for the most part doing the work.
The CEO and Sr. Management team is completely dysfunctional and makes poor business strategy decisions repeatedly.
Advice to Management
Fire the CEO and reorg the board.
Let us know if we're missing any workplace or industry recognition –
StemCells hopes a small focus will mean big business. The company discovers cell-based therapies to treat diseases of the central nervous system (CNS), such as cerebral palsy and macular degeneration, as well as spinal cord injury. It is researching stem cell and progenitor cell (cells that have developed from stem cells) therapies to repair neural tissue damaged by disease and injury, and has discovered markers for CNS stem cells and a way to reproduce them for transplant. Its lead therapy candidate may treat Batten disease, a fatal genetic enzyme deficiency. In addition ...